Research Support

Innovative Health Initiative

Profile: Innovative Health Initiative (IHI) is a public-private partnership (PPP) between the European Union (represented by the European Commission) and European life science industries (i.e. trade associations COCIR, EFPIA / Vaccines Europe, EuropaBio and MedTech Europe). All IHI projects should be PPPs strengthening industry collaboration with academics and other actors in the healthcare system.

Target group: consortia consisting of the relevant stakeholders (e.g. scientists from academia, research organisations, diverse industry sectors, SMEs, mid-sized companies, hospitals and patients’ organisations) who want to participate in ground-breaking, cross-sectoral collaborative projects that deliver tangible benefits for patients on a European level as described in the call topic text. Please see the IHI website for upcoming and open call topics.

Amount: the total budget for IHI 2021-2027 is € 2.4 billion. The IHI contribution per proposal varies per call topic. All projects require a 45% contribution of the total project budget provided by the constituent or affiliated entities of private members and/or contributing partners. For two stage calls the pre-identified industry consortium, providing the 45% contribution, is already identified in the call topic text. For single stage calls the consortia will need to ensure that the 45% contribution of the total budget is met.

Horizon Europe

Under construction